CBC-Backed Hasten Biopharmaceutical Announces Acquisition of 14 Celltrion Legacy Products

Contributed by: PR Newswire

Tags

CBC-Group

More Like This

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates

Celltrion Announces the Acquisition of iQone Healthcare Switzerland, Further Building Its Expertise and Foothold in Europe

(Graphic: Business Wire)

PHC Unveils Prototype of LiCellGrow, New Cell Expansion System to Support Development of Cell and Gene Therapy Products Manufacturing Process

Zymfentra® (Photo: Celltrion)

Celltrion, Inc. & Celltrion Healthcare Co., Ltd. Announce Shareholders Approval of Merger

Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

ACCESSWIRE associated0

HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies

PR Newswire associated0

Bio X Cell Announces Board of Director Appointments

SBC to leverage operational synergies and implement growth strategies to launch into new verticals and geographies (Graphic: Business Wire)

SBC Medical Group Holdings Announces Definitive Agreement to Acquire, Aesthetic Healthcare Holdings Pte. Ltd, a Multi-Unit Owner of Aesthetic Treatment Clinics in Singapore